These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1397951)

  • 1. [Clinical and immune hematologic problems in prenatal prevention of Rhesus sensitization].
    Marzusch K; Mayer G; Gonser M; Menton M
    Geburtshilfe Frauenheilkd; 1992 Sep; 52(9):516-9. PubMed ID: 1397951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of new recommendations on routine antenatal prevention of rhesus immunization: an appraisal based on a retrospective analysis of all cases observed in two French administrative areas of 3 million inhabitants.
    Boulet S; Krause C; Tixier H; Bardou M; Sagot P
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):65-70. PubMed ID: 19482403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibody detection after antepartal rhesus prophylaxis: normal values or sensitization].
    Behrens O; Bader W; Holle W; Maas DH; Schneider J
    Geburtshilfe Frauenheilkd; 1993 May; 53(5):342-5. PubMed ID: 8514107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gel agglutination test--a new test system for semiquantitative detection of feto-maternal transfusion in Rhesus incompatibility].
    David M; Stelzer A; Wittmann G; Dudenhausen JW; Salama A
    Z Geburtshilfe Neonatol; 1999; 203(6):241-5. PubMed ID: 10612196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemolytic disease of the newborn: the new NICE guidelines.
    Thompson J
    J Fam Health Care; 2002; 12(5):133-6. PubMed ID: 12449064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fetomaternal incompatibility due to Rhesus erythrocyte antigens other than antigen D].
    Faille N; Kremp O; Risbourg B; Olewniczak G; Maingourd Y; Dieval J; Delobel J
    Ann Pediatr (Paris); 1984 Oct; 31(8):657-60. PubMed ID: 6437316
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 9. Fetal anemia due to non-Rhesus-D red-cell alloimmunization.
    Moise KJ
    Semin Fetal Neonatal Med; 2008 Aug; 13(4):207-14. PubMed ID: 18396474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
    Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
    BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rhesus immunization in a rhesus-positive pregnant woman: fetal erythroblastosis caused by the rhesus antibody anti-C].
    Konstantin-Hansen KF; Larsen HL; Hejl M
    Ugeskr Laeger; 1989 Jun; 151(24):1553. PubMed ID: 2506685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-D human immunoglobulin: new preparation. Important in young Rh D (-) women.
    Prescrire Int; 2001 Feb; 10(51):4-7. PubMed ID: 11503859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.
    Ben-David G; Sheiner E; Levy A; Erez O; Mazor M
    J Matern Fetal Neonatal Med; 2008 Apr; 21(4):255-9. PubMed ID: 18330822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical aspects of prenatal prevention of rhesus incompatibility].
    Maas DH
    Beitr Infusionsther; 1992; 30():425-30. PubMed ID: 1284752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transvaginal bleeding in pregnancy, as risk factor of Rhesus-D antigen isoimmunization].
    Hernández-Andrade E; Ahued-Ahued JR
    Salud Publica Mex; 2003; 45(6):492-6. PubMed ID: 14974293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of Rhesus incompatibility and viral safety].
    Kirchebner C; Sölder E; Schönitzer D
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):281-3. PubMed ID: 7950294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region].
    Huchet J; Dallemagne S; Huchet C; Brossard Y; Larsen M; Parnet-Mathieu F
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):101-11. PubMed ID: 3035003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of Rh-D immunoprophylaxis with hyperimmune anti-D-immunoglobulin on the occurrence of RhD immunization in pregnancy].
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
    Lijec Vjesn; 1997 Jul; 119(7):189-93. PubMed ID: 9471477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Rh negative pregnant women who attended the antenatal clinic and delivered in Rajavithi Hospital: 2000-2005.
    Puangsricharern A; Suksawat S
    J Med Assoc Thai; 2007 Aug; 90(8):1491-4. PubMed ID: 17926974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of isoimmunization in the presence of multiple maternal antibodies.
    Spong CY; Porter AE; Queenan JT
    Am J Obstet Gynecol; 2001 Aug; 185(2):481-4. PubMed ID: 11518913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.